coronavirus vaccines that Pfizer Inc and BioNTech SE are jointly developing. It is the latest in a series of similar agreements with other vaccine companies.
US President Donald Trump, during a briefing on Wednesday, described the agreement as “historic."We think we have a winner there.
We also think we have other companies right behind that are doing very well in the vaccines, long ahead of schedule," he told reporters.Under the agreement, the US government with will pay Pfizer nearly $2 billion for a December delivery of 10 crore doses of a COVID-19 vaccine the pharmaceutical company if approved by the Food and Drug Administration.